{"input_url":"https://insilico.com/news/lgv150926en-ai-driven-longevity-vaccines","gnews_decode":"https://insilico.com/news/lgv150926en-ai-driven-longevity-vaccines","http_status":200,"final_url":"https://insilico.com/news/lgv150926en-ai-driven-longevity-vaccines","html_length":43639,"trafilatura_result":"ok","text_length":6746,"text_preview":"The program applies generative AI and programmable RNA medicine to design single-administration, self-limiting in vivo cell therapies that clear the earliest culprit cells of age-related disease.\n- The new research initiative aims to develop programmable, self-limiting preventive treatment to elimin","verdict":"OK"}